Simultaneous determination of favipiravir and surrogates of its metabolites by means of heart-cutting bidimensional liquid chromatography (2D-LC)
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Simultaneous determination of favipiravir and surrogates of its metabolites by means of heart-cutting bidimensional liquid chromatography (2D-LC)
Authors
Keywords
-
Journal
ANALYTICAL BIOCHEMISTRY
Volume -, Issue -, Pages 115375
Publisher
Elsevier BV
Online
2023-11-04
DOI
10.1016/j.ab.2023.115375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5′-triphosphate exposure to support posology for SARS-CoV-2
- (2021) Henry Pertinez et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Development and validation of a sensitive, fast and simple LC-MS / MS method for the quantitation of favipiravir in human serum
- (2021) Duygu Eryavuz Onmaz et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Green micellar solvent-free HPLC and spectrofluorimetric determination of favipiravir as one of COVID-19 antiviral regimens
- (2021) Ibraam E. Mikhail et al. MICROCHEMICAL JOURNAL
- The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
- (2021) Soheil Hassanipour et al. Scientific Reports
- Menthol-assisted homogenous liquid-liquid microextraction for HPLC/UV determination of favipiravir as an antiviral for COVID-19 in human plasma
- (2021) Inas A. Abdallah et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection
- (2020) Yin‐Xiao Du et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Development of an achiral-chiral 2-dimensional heart-cutting platform for enhanced pharmaceutical impurity analysis
- (2020) Ravindra Suryakant Hegade et al. JOURNAL OF CHROMATOGRAPHY A
- The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold
- (2018) Katherine L. Seley-Radtke et al. ANTIVIRAL RESEARCH
- Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus
- (2018) Sandra L. Bixler et al. ANTIVIRAL RESEARCH
- Two-Dimensional Liquid Chromatography (2D-LC) in Pharmaceutical Analysis: Applications Beyond Increasing Peak Capacity
- (2018) Imad A. Haidar Ahmad et al. CHROMATOGRAPHIA
- The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold
- (2018) Mary K. Yates et al. ANTIVIRAL RESEARCH
- Validation of a two-dimensional liquid chromatography method for quality control testing of pharmaceutical materials
- (2017) Samuel H. Yang et al. JOURNAL OF CHROMATOGRAPHY A
- Two-dimensional liquid chromatography in pharmaceutical analysis. Instrumental aspects, trends and applications
- (2017) Marion Iguiniz et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Two-Dimensional Liquid Chromatography: A State of the Art Tutorial
- (2016) Dwight R. Stoll et al. ANALYTICAL CHEMISTRY
- Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses
- (2016) Vincent Madelain et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hydrophilic interaction chromatography coupled to tandem mass spectrometry in the presence of hydrophilic ion-pairing reagents for the separation of nucleosides and nucleotide mono-, di- and triphosphates
- (2015) María Mateos-Vivas et al. JOURNAL OF CHROMATOGRAPHY A
- Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase
- (2013) Hidehiro Sangawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells
- (2009) D. F. Smee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- T-705 (favipiravir) activity against lethal H5N1 influenza A viruses
- (2009) M. Kiso et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now